Commercial-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
https://www.asn-online.org/education/kidneyweek/2022/KW22_Calliditas2228_Spotlight.pdf
Contact this Exhibitor